论文部分内容阅读
目的:对铝碳酸镁联合奥美拉唑治疗胃溃疡合并胃出血的临床效果进行探讨。方法:随机选取2016年2月-2017年2月在我院进行治疗的胃溃疡合并胃出血患者共87例,使用随机方法将患者分为A组(45例)和B组(42例),A组患者使用铝碳酸镁联合奥美拉唑进行治疗,B组患者仅使用奥美拉唑进行治疗,在治疗结束后对两组患者临床疗效和不良反应的具体情况进行比较。结果:A组患者痊愈率、显效率、有效率、无效率以及总有效率分别为84.44%、6.67%、4.44%、4.44%、95.56%,B组患者痊愈率、显效率、有效率、无效率以及总有效率分别为69.05%、2.38%、9.52%、19.05%、80.95%,A组患者在治疗总有效率方面高于B组,并且P<0.05有统计学意义;A组患者不良反应发生率为6.67%,B组患者不良反应发生率为23.81%,后者明显高于前者(P<0.05),差异较为显著。结论:将铝碳酸镁和奥美拉唑进行联合使用治疗胃溃疡合并胃出血的疗效较好,患者出现不良反应的几率较小,有较大的临床推广价值。
Objective: To investigate the clinical effect of combination of magnesium aluminum carbonate and omeprazole on gastric ulcer combined with gastric hemorrhage. Methods: A total of 87 patients with gastric ulcer and gastric hemorrhage who were treated in our hospital from February 2016 to February 2017 were selected randomly. Patients were divided into group A (n = 45) and group B (n = 42) Patients in group A were treated with magnesium aluminum carbonate combined with omeprazole. Patients in group B were treated with omeprazole only. After treatment, the clinical efficacy and adverse reactions of the two groups were compared. Results: The cure rate, effective rate, effective rate, inefficiency and total effective rate in group A were 84.44%, 6.67%, 4.44%, 4.44% and 95.56% respectively. The cure rate, effective rate, Efficiency and total effective rate were 69.05%, 2.38%, 9.52%, 19.05% and 80.95%, respectively. The total effective rate in group A was higher than that in group B, and P <0.05 was statistically significant. The adverse reactions in group A The incidence was 6.67%. The incidence of adverse reactions in group B was 23.81%, which was significantly higher than the former (P <0.05). The difference was significant. Conclusion: The combined use of aluminum magnesium carbonate and omeprazole in the treatment of gastric ulcer combined with gastric bleeding has a good curative effect, and the patients have less risk of adverse reactions and have greater clinical promotion value.